Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-2-15
pubmed:abstractText
Chronic obstructive pulmonary disease (COPD) is a major public health problem and its impact is increasing. Only smoking cessation and oxygen for -hypoxaemic patients have been shown to alter mortality, but modern pharmacological therapies can improve symptoms, lung function and quality of life. Treatment guidelines emphasise the use of bronchodilators as first-line treatment for COPD but make few recommendations about choosing a specific agent. In this review, the results of recent studies are examined to provide evidence-based guidance for the selection of appropriate maintenance therapy. Guidelines also support the use of inhaled corticosteroids in patients with more advanced disease, and the role of these agents is discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1744-7666
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13-25
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Maintenance pharmacotherapy of chronic obstructive pulmonary disease: an evidence-based approach.
pubmed:affiliation
The University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine, 215 THT1900 University Blvd, Birmingham, Al 35294, USA. mdransfield99@msn.com
pubmed:publicationType
Journal Article, Comparative Study, Review